Cases & Deals

Amoéba completes €14.7 million private placement of new shares

Clients Amoéba SAS

Jones Day represented Amoéba SAS, a developer of sustainable organic biocide capable of mitigating bacterial risk in water systems, in connection with the €14.7 million (US$16.5 million) private placement of new shares to European and American investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.